Ameriprise
VIVS

Ameriprise’s VivoSim Labs VIVS Stock Holding History

Ameriprise’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-124
Closed -$16K – 3800
2020
Q2 		$16K Buy
+124
New +$15.1K ﹤0.01% 3649
2019
Q4 		– Sell
-66
Closed -$4K – 3774
2019
Q3 		$4K Sell
66
-5
-7% -$421 ﹤0.01% 3702
2019
Q2 		$9K Hold
71
– – ﹤0.01% 3714
2019
Q1 		$17K Buy
71
+23
+48% +$5.79K ﹤0.01% 3671
2018
Q4 		$11K Buy
48
+4
+9% +$1.01K ﹤0.01% 3607
2018
Q3 		$12K Buy
+44
New +$13.2K ﹤0.01% 3693
2018
Q1 		– Sell
-595
Closed -$191K – 3704
2017
Q4 		$191K Sell
595
-163
-22% -$60.6K ﹤0.01% 3479
2017
Q3 		$404K Buy
758
+678
+848% +$361K ﹤0.01% 3294
2017
Q2 		$51K Sell
80
-7
-8% -$4.71K ﹤0.01% 3683
2017
Q1 		$66K Buy
87
+9
+12% +$7.13K ﹤0.01% 3566
2016
Q4 		$64K Buy
78
+6
+8% +$4.76K ﹤0.01% 3793
2016
Q3 		$66K Sell
72
-11
-13% -$10.8K ﹤0.01% 3686
2016
Q2 		$74K Hold
83
– – ﹤0.01% 3654
2016
Q1 		$43K Buy
83
+1
+1% +$508 ﹤0.01% 3682
2015
Q4 		$49K Sell
82
-13
-14% -$9.43K ﹤0.01% 3791
2015
Q3 		$61K Sell
95
-3
-3% -$2.28K ﹤0.01% 3764
2015
Q2 		$85K Buy
98
+27
+38% +$30.2K ﹤0.01% 3931
2015
Q1 		$61K Buy
71
+10
+16% +$13.8K ﹤0.01% 3711
2014
Q4 		$106K Buy
61
+16
+36% +$24.6K ﹤0.01% 3581
2014
Q3 		$68K Buy
45
+11
+32% +$19.9K ﹤0.01% 3856
2014
Q2 		$69K Buy
34
+23
+209% +$38.5K ﹤0.01% 3763
2014
Q1 		$20K Buy
+11
New +$25.5K ﹤0.01% 4213

Other funds holding VIVS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ameriprise's VIVS Position: Q3 2020 in Review

Ameriprise sold out of VivoSim Labs (VIVS) in Q3 2020, closing a stake of 124 shares — an estimated $16K sold.

Ameriprise first reported a position in VIVS in Q1 2014 and held it in 22 quarters. The position peaked at $404K in Q3 2017. 46 funds tracked by Wall St. Rank hold VIVS as of Q3 2020.

  • Ameriprise reported no remaining VivoSim Labs position as of Q3 2020 after selling out during the quarter.
  • Ameriprise sold 124 VivoSim Labs shares in Q3 2020, an estimated $16K.
  • Ameriprise first reported a position in VivoSim Labs in Q1 2014 and held it in 22 quarters.
  • Ameriprise's VivoSim Labs position peaked at $404K in Q3 2017.
  • 46 funds tracked by Wall St. Rank held VivoSim Labs as of Q3 2020.

Based on Ameriprise's 13F filing for Q3 2020, filed 16 Nov 2020.